BR112023021606A2 - Formas sólidas de modulador de hemoglobina - Google Patents
Formas sólidas de modulador de hemoglobinaInfo
- Publication number
- BR112023021606A2 BR112023021606A2 BR112023021606A BR112023021606A BR112023021606A2 BR 112023021606 A2 BR112023021606 A2 BR 112023021606A2 BR 112023021606 A BR112023021606 A BR 112023021606A BR 112023021606 A BR112023021606 A BR 112023021606A BR 112023021606 A2 BR112023021606 A2 BR 112023021606A2
- Authority
- BR
- Brazil
- Prior art keywords
- solid forms
- forms
- compound
- hemoglobin
- modulator
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188833P | 2021-05-14 | 2021-05-14 | |
| PCT/US2022/029289 WO2022241278A1 (en) | 2021-05-14 | 2022-05-13 | Solid forms of a modulator of hemoglobin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023021606A2 true BR112023021606A2 (pt) | 2023-12-19 |
Family
ID=82020064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023021606A BR112023021606A2 (pt) | 2021-05-14 | 2022-05-13 | Formas sólidas de modulador de hemoglobina |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11851424B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4337659A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024520897A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102968809B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117337285A (cg-RX-API-DMAC7.html) |
| AR (1) | AR126649A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022273787B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023021606A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219786A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023012156A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202311254A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022241278A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202309517B (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024007064A (es) * | 2021-12-10 | 2024-06-20 | Global Blood Therapeutics Inc | Metodos de administracion de un modulador de hemoglobina. |
| EP4727555A1 (en) * | 2023-06-13 | 2026-04-22 | Global Blood Therapeutics, Inc. | (s)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicotinoyl)morpholin-3-yl)methoxy)benzaldehyd for use in the treatment of sickle cell disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US4432987A (en) * | 1982-04-23 | 1984-02-21 | Pfizer Inc. | Crystalline benzenesulfonate salts of sultamicillin |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| JP6426694B2 (ja) * | 2013-03-15 | 2018-11-21 | グローバル ブラッド セラピューティクス インコーポレイテッド | ヘモグロビンの修飾のための化合物及びその使用 |
| PT3880654T (pt) * | 2018-11-19 | 2022-04-08 | Global Blood Therapeutics Inc | Compostos de 2-formil-3-hidroxifeniloximetil capazes de modular hemoglobina |
| AR126648A1 (es) * | 2021-05-14 | 2023-11-01 | Global Blood Therapeutics Inc | Métodos para hacer un modulador de hemoglobina |
| MX2024007064A (es) * | 2021-12-10 | 2024-06-20 | Global Blood Therapeutics Inc | Metodos de administracion de un modulador de hemoglobina. |
-
2022
- 2022-05-13 BR BR112023021606A patent/BR112023021606A2/pt unknown
- 2022-05-13 KR KR1020237043235A patent/KR102968809B1/ko active Active
- 2022-05-13 EP EP22729906.2A patent/EP4337659A1/en active Pending
- 2022-05-13 CN CN202280035091.5A patent/CN117337285A/zh active Pending
- 2022-05-13 AR ARP220101301A patent/AR126649A1/es not_active Application Discontinuation
- 2022-05-13 MX MX2023012156A patent/MX2023012156A/es unknown
- 2022-05-13 WO PCT/US2022/029289 patent/WO2022241278A1/en not_active Ceased
- 2022-05-13 AU AU2022273787A patent/AU2022273787B2/en active Active
- 2022-05-13 US US17/744,537 patent/US11851424B2/en active Active
- 2022-05-13 JP JP2023569774A patent/JP2024520897A/ja active Pending
- 2022-05-13 CA CA3219786A patent/CA3219786A1/en active Pending
- 2022-05-13 TW TW111118076A patent/TW202311254A/zh unknown
-
2023
- 2023-10-11 ZA ZA2023/09517A patent/ZA202309517B/en unknown
- 2023-11-01 US US18/499,491 patent/US12473277B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024520897A (ja) | 2024-05-27 |
| AR126649A1 (es) | 2023-11-01 |
| TW202311254A (zh) | 2023-03-16 |
| KR20240008356A (ko) | 2024-01-18 |
| WO2022241278A1 (en) | 2022-11-17 |
| MX2023012156A (es) | 2023-10-26 |
| CA3219786A1 (en) | 2022-11-17 |
| AU2022273787A1 (en) | 2023-10-26 |
| US11851424B2 (en) | 2023-12-26 |
| ZA202309517B (en) | 2024-06-26 |
| US12473277B2 (en) | 2025-11-18 |
| EP4337659A1 (en) | 2024-03-20 |
| CN117337285A (zh) | 2024-01-02 |
| US20220363674A1 (en) | 2022-11-17 |
| KR102968809B1 (ko) | 2026-05-26 |
| AU2022273787B2 (en) | 2025-04-03 |
| US20240076290A1 (en) | 2024-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015001874A2 (pt) | sais e formas sólidas de (s) -3- (4 - ((4-morfolinometil) benzil) oxi) -1-oxoisoindolin-2-il) -piperidina-2,6-diona e composições que compreendem e métodos de utilização das mesmas | |
| DK0670310T3 (da) | Bisulfitaddukt af argininaldehyder egnet som thrombininhibitorer og som antikoagulanter | |
| CL2021001561A1 (es) | Inhibidores de apol1 y sus métodos de uso | |
| BR122012009534C8 (pt) | 4-[2-(4-metil-fenil-sulfanil)-fenil]-piperidina, seu uso e composição farmacêutica compreendendo o referido composto | |
| FR2708197B1 (fr) | Nouvelles compositions à base d'eau oxygénée et leur utilisation comme fixateurs pour permanentes. | |
| BRPI0820474B8 (pt) | uso do composto 1-[2-(2,4-dimetil-fenil-sulfanil)-fenil]-piperazina ou de sais farmaceuticamente aceitáveis do mesmo | |
| BR0306957A (pt) | Herbicidas | |
| BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
| ATE547944T1 (de) | Desinfizierende zusammensetzungen enthaltend glycerin-monoalkylethern und bis- pyridiniumalkanen und deren verwendung als hautantiseptika | |
| LTPA2010007I1 (lt) | 3'-(2Z)-1-(3,4-Dimetilfenil)-1,5-dihidro-3-metil-5-okso-4H-pirazol-4-ilidenhidrazino-2'-hidroksi-1,1'-bifenil-3-karboksirūgšties bis-(monoetanolaminas) | |
| MXPA02009381A (es) | Composicion para tincion de fibras queratinicas humanas que contiene un colorante monoazoico, monocationico particular. | |
| EP1188747A4 (en) | PHENOXYPROPYLAMIN DERIVATIVES | |
| ATE385430T1 (de) | Verwendung eines haarbehandlungsmittel mit gehalt an einer polymerkombination | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| ECSP22044316A (es) | Mol?culas de fusi?n del ecd de siglec-9 y m?todos de uso de estas | |
| ZA202309517B (en) | Solid forms of a modulator of hemoglobin | |
| SA520412549B1 (ar) | تركيبة حبر حيوي لرقاقة تجديد أدمة، طريقة لتصنيع رقاقة تجديد أدمة مخصصة حسب الحاجة باستخدامها، ورقاقة تجديد أدمة مخصصة حسب الحاجة مصنوعة باستخدام طريقة تصنيع. | |
| BR0308055A (pt) | Processo para a preparação de compostos de azo catiÈnicos | |
| CY1112878T1 (el) | Νεο αλας βενζοϋλογονανιδινης | |
| DK1438294T3 (da) | Fremkalderkomponenter og deres anvendelse til farvning af keratinfibre | |
| DE602004003087D1 (de) | Färbemittel zum Färben von menschlicher Keratinmaterie, enthaltend einen fluoreszierenden Farbstoff und einen unlöslichen kondizionierenden Polyorganosiloxanpolymer, Verfahren und Verwendung | |
| ATE347922T1 (de) | Fluoreszenzfarbstoffzusammensetzung zum färben von menschlichen keratinfasern | |
| ATE547092T1 (de) | 2-(amino oder substituierte amino)-3,5,6- substituierte phenolverbindungen, haarfärbemittel und deren verwendung | |
| DE50109698D1 (de) | N-heteroarylmethyl-m-phenylendiamin-derivate enthaltende färbemittel für keratinfasern sowie neue n-heteroarylmethyl-m-phenylendiamin-derivate | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |